Agree, a lot going on with the prospect for Optiscan to be providing remote digital pathology in three applications, Neuro, Oral and breast and maybe a few research instruments. Nice that they have finally set out a timeline to achieve targets. Orders first five months also look promising, Zeiss must be gaining traction with Convivo!!
Ann: OIL Managing Director's Presentation & Chair's Address, page-4
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OIL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $133.6M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 16.5¢ | 16.0¢ | $14.74K | 91.19K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 49973 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 43713 | 2 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| OIL (ASX) Chart |